These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2192070)

  • 21. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormesis without cell killing.
    Cox LA
    Risk Anal; 2009 Mar; 29(3):393-400. PubMed ID: 18793280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unifying concept for assessing toxicological interactions: changes in slope.
    Gennings C; Carter WH; Carchman RA; Teuschler LK; Simmons JE; Carney EW
    Toxicol Sci; 2005 Dec; 88(2):287-97. PubMed ID: 16081521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. U-shaped dose-response curves: implications for risk characterization of essential elements and other chemicals.
    Douron M
    J Toxicol Environ Health A; 2010; 73(2):181-6. PubMed ID: 20077289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating biologically based models into assessments of risk from chemical contaminants.
    Bull RJ; Conolly RB; De Marini DM; MacPhail RC; Ohanian EV; Swenberg JA
    J Am Water Works Assoc; 1993 Mar; 85(3):49-52. PubMed ID: 11538064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The U.S. Environmental Protection Agency's risk assessment guidelines.
    Jarabek AM; Farland WH
    Toxicol Ind Health; 1990 Oct; 6(5):199-216. PubMed ID: 2274984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment.
    Calabrese EJ
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):125-36. PubMed ID: 15163548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental toxicology: adequacy of current methods.
    Peters PW
    Food Addit Contam; 1998; 15 Suppl():55-62. PubMed ID: 9602913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Historical blunders: how toxicology got the dose-response relationship half right.
    Calabrese EJ
    Cell Mol Biol (Noisy-le-grand); 2005 Dec; 51(7):643-54. PubMed ID: 16359616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
    Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
    Toxicol Sci; 2004 Nov; 82(1):279-96. PubMed ID: 15254341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-level chemical sensitivity: a perspective from behavioral toxicology.
    Weiss B
    Toxicol Ind Health; 1994; 10(4-5):605-17. PubMed ID: 7778118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk assessment for benefits analysis: framework for analysis of a thyroid-disrupting chemical.
    Axelrad DA; Baetcke K; Dockins C; Griffiths CW; Hill RN; Murphy PA; Owens N; Simon NB; Teuschler LK
    J Toxicol Environ Health A; 2005 Jun 11-25; 68(11-12):837-55. PubMed ID: 16020180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Potential role of hormesis in risk assessment in occupational toxicology].
    Iavicoli I; Carelli G
    G Ital Med Lav Ergon; 2003; 25 Suppl(3):174-5. PubMed ID: 14979136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Toxicological basis for evaluating health risk].
    Rolecki R; Dutkiewicz T; Kończalik J
    Med Pr; 1992; 43(3):173-81. PubMed ID: 1406237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Issues in qualitative and quantitative risk analysis for developmental toxicology.
    Kimmel CA; Gaylor DW
    Risk Anal; 1988 Mar; 8(1):15-20. PubMed ID: 3375503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormesis: U-shaped dose responses and their centrality in toxicology.
    Calabrese EJ; Baldwin LA
    Trends Pharmacol Sci; 2001 Jun; 22(6):285-91. PubMed ID: 11395156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.